Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
52,664,292
-
Total 13F shares
-
1,486,052
-
Share change
-
+683,730
-
Total reported value
-
$4,472,066
-
Price per share
-
$3.01
-
Number of holders
-
20
-
Value change
-
+$2,057,939
-
Number of buys
-
10
-
Number of sells
-
7
Institutional Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q4 2022
As of 31 Dec 2022,
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,486,052 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., AlphaCentric Advisors LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and Bank of New York Mellon Corp.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.